IL136215A0 - Spheroids, preparation method and pharmaceutical compositions - Google Patents

Spheroids, preparation method and pharmaceutical compositions

Info

Publication number
IL136215A0
IL136215A0 IL13621598A IL13621598A IL136215A0 IL 136215 A0 IL136215 A0 IL 136215A0 IL 13621598 A IL13621598 A IL 13621598A IL 13621598 A IL13621598 A IL 13621598A IL 136215 A0 IL136215 A0 IL 136215A0
Authority
IL
Israel
Prior art keywords
spheroids
preparation
pharmaceutical compositions
pharmaceutical preparations
tiagabine
Prior art date
Application number
IL13621598A
Other languages
English (en)
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of IL136215A0 publication Critical patent/IL136215A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13621598A 1997-11-21 1998-11-19 Spheroids, preparation method and pharmaceutical compositions IL136215A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714631A FR2771291B1 (fr) 1997-11-21 1997-11-21 Spheroides, procede de preparation et compositions pharmaceutiques
PCT/IB1998/001911 WO1999026608A1 (fr) 1997-11-21 1998-11-19 Spheroides, procede de preparation et compositions pharmaceutiques

Publications (1)

Publication Number Publication Date
IL136215A0 true IL136215A0 (en) 2001-05-20

Family

ID=9513635

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13621598A IL136215A0 (en) 1997-11-21 1998-11-19 Spheroids, preparation method and pharmaceutical compositions
IL136215A IL136215A (en) 1997-11-21 2000-05-18 Speroids, their preparation process and pharmaceuticals

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL136215A IL136215A (en) 1997-11-21 2000-05-18 Speroids, their preparation process and pharmaceuticals

Country Status (29)

Country Link
US (1) US6077544A (da)
EP (1) EP1032374B1 (da)
JP (1) JP2001523706A (da)
KR (1) KR100502938B1 (da)
CN (1) CN1223341C (da)
AT (1) ATE246496T1 (da)
AU (1) AU744580B2 (da)
BG (1) BG65117B1 (da)
BR (1) BR9814672A (da)
CA (1) CA2310147C (da)
CZ (1) CZ299110B6 (da)
DE (1) DE69817010T2 (da)
DK (1) DK1032374T3 (da)
EA (1) EA003324B1 (da)
ES (1) ES2203989T3 (da)
FR (1) FR2771291B1 (da)
HR (1) HRP20000323B1 (da)
HU (1) HU230053B1 (da)
IL (2) IL136215A0 (da)
MX (1) MXPA00004959A (da)
NO (1) NO329728B1 (da)
NZ (1) NZ504662A (da)
PL (1) PL193878B1 (da)
PT (1) PT1032374E (da)
SK (1) SK284493B6 (da)
TR (1) TR200002130T2 (da)
WO (1) WO1999026608A1 (da)
YU (1) YU31000A (da)
ZA (1) ZA9810631B (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
US6794411B1 (en) 1999-04-06 2004-09-21 Laboratoire Des Produits Ethiques Ethypharm Drinkable ibuprofen pharmaceutical suspension
FR2794646B1 (fr) * 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
US7018821B2 (en) 2001-06-22 2006-03-28 Genencor International, Inc. Highly impact-resistant granules
AR034813A1 (es) † 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
WO2003084517A2 (fr) * 2002-04-09 2003-10-16 Flamel Technologies Suspension orale de microcapsules d’amoxicilline
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US9107804B2 (en) * 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
NZ523946A (en) * 2003-01-31 2004-06-25 Carl Ernest Alexander Portable hygiene compositions comprising a semi-solid gel and active ingredients in bead form for use in personal oral, dental or skin care
ES2221804B1 (es) * 2003-06-18 2006-04-01 Lipofoods, S.L. Microcapsulas para la administracion de ingredientes activos.
US7569236B2 (en) * 2003-10-10 2009-08-04 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
FR2861990B1 (fr) 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
US8236349B2 (en) * 2004-04-12 2012-08-07 Bend Research Inc. Taste-masked drugs in rupturing multiparticulates
US20070224269A1 (en) * 2004-06-10 2007-09-27 Rubino Orapin P Controlled Release Pharmaceutical Formulation
FR2883179B1 (fr) * 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US20100233257A1 (en) * 2006-06-09 2010-09-16 Ethypharm Low dose sublingual tablets of opioid analgesics and preparation process
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
US10357462B2 (en) * 2006-11-30 2019-07-23 Ben Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
US11116728B2 (en) 2006-11-30 2021-09-14 Bend Research, Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
EP2468263A1 (en) 2010-12-23 2012-06-27 Laboratorios Del. Dr. Esteve, S.A. Compressed solid dosage forms
CN114772256B (zh) 2018-05-11 2024-05-17 斯多里机械有限责任公司 快速更换式真空星轮组件和缩颈机
JP7312196B2 (ja) 2018-05-11 2023-07-20 ストール マシーナリ カンパニー，エルエルシー 回転マニホールド
BR112020022970A2 (pt) 2018-05-11 2021-02-02 Stolle Machinery Company, Llc recursos de mudança rápida de conjunto de alimentação
CN115673132A (zh) 2018-05-11 2023-02-03 斯多里机械有限责任公司 成型站和缩颈机
US11117180B2 (en) 2018-05-11 2021-09-14 Stolle Machinery Company, Llc Quick change tooling assembly
BR112020022859A2 (pt) 2018-05-11 2021-02-23 Stolle Machinery Company, Llc conjunto de inspeção completa de conjunto de alimentação
CN112118920B (zh) 2018-05-11 2023-04-14 斯多里机械有限责任公司 驱动组件
US11420242B2 (en) 2019-08-16 2022-08-23 Stolle Machinery Company, Llc Reformer assembly

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684516A (en) * 1983-08-01 1987-08-04 Alra Laboratories, Inc. Sustained release tablets and method of making same
CA1338596C (en) * 1988-09-27 1996-09-17 Hiroyoshi Koyama Granules having core and their production
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
FR2692146B1 (fr) * 1992-06-16 1995-06-02 Ethypharm Sa Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
US5681582A (en) * 1993-06-14 1997-10-28 Janssen Pharmaceutica N.V. Extended release, film-coated tablet of astemizole and pseudoephedrine
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
FR2771292B1 (fr) * 1997-11-21 2000-02-18 Ethypharm Lab Prod Ethiques Spheroides contenant de la tiagabine, procede de preparation et compositions pharmaceutiques

Also Published As

Publication number Publication date
ES2203989T3 (es) 2004-04-16
DE69817010D1 (de) 2003-09-11
US6077544A (en) 2000-06-20
AU1170499A (en) 1999-06-15
CA2310147C (fr) 2010-05-25
FR2771291B1 (fr) 2000-02-25
DE69817010T2 (de) 2004-05-27
KR100502938B1 (ko) 2005-07-25
CA2310147A1 (fr) 1999-06-03
HU230053B1 (hu) 2015-06-29
DK1032374T3 (da) 2003-11-24
PT1032374E (pt) 2003-12-31
MXPA00004959A (es) 2002-10-17
IL136215A (en) 2006-12-31
NO20002605D0 (no) 2000-05-19
PL193878B1 (pl) 2007-03-30
BG65117B1 (bg) 2007-03-30
ZA9810631B (en) 1999-05-24
TR200002130T2 (tr) 2000-12-21
HUP0100562A3 (en) 2002-08-28
FR2771291A1 (fr) 1999-05-28
NO20002605L (no) 2000-07-05
HRP20000323B1 (en) 2006-07-31
BG104511A (en) 2001-04-30
ATE246496T1 (de) 2003-08-15
EA003324B1 (ru) 2003-04-24
NO329728B1 (no) 2010-12-06
WO1999026608A1 (fr) 1999-06-03
JP2001523706A (ja) 2001-11-27
YU31000A (sh) 2002-11-15
AU744580B2 (en) 2002-02-28
BR9814672A (pt) 2000-10-03
PL340659A1 (en) 2001-02-12
CZ20001849A3 (cs) 2000-10-11
HRP20000323A2 (en) 2001-06-30
EA200000548A1 (ru) 2000-12-25
EP1032374B1 (fr) 2003-08-06
KR20010032329A (ko) 2001-04-16
CZ299110B6 (cs) 2008-04-23
CN1282239A (zh) 2001-01-31
CN1223341C (zh) 2005-10-19
NZ504662A (en) 2002-09-27
EP1032374A1 (fr) 2000-09-06
SK284493B6 (sk) 2005-05-05
HUP0100562A2 (hu) 2002-05-29
SK7562000A3 (en) 2001-06-11

Similar Documents

Publication Publication Date Title
IL136215A0 (en) Spheroids, preparation method and pharmaceutical compositions
ZA9810630B (en) Spheroids containing tiagabine preparation process and pharmaceutical compositions
HK1002017A1 (en) Lyospheres comprising gonadotropin
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
IL149154A0 (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same
CA2335551A1 (en) Thyroid hormone analogues and methods for their preparation
WO1998019697A3 (en) Novel pharmaceutical compositions
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
DK0557389T3 (da) Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
WO2001024803A3 (en) Pharmaceutical compositions containing copper, salicylic acid and vitamines c
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
PL338294A1 (en) Derivatives of streptogramins, method of obtaining them and compositions containing such derivatives
HUP0202305A3 (en) Novel vitamin d analogues, process for their preparation and pharmaceutical compositions containing them
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
EG19285A (en) Process for the preparation of an extracellular exopolymer, the exopolmer obtained there of and pharmaceutical compositions containing the same
AU6452300A (en) Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed